Business
Appointment of Director & Grant of Options
Appointment of Director & Grant of Options.
About this update from Kanabo Group Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 3962D\n Kanabo Group PLC\n 29 June 2021\n \n \n \n \n 29 June 2021\n \n \n Kanabo Group Plc\n \n \n (\"Kanabo\" or \"the Company\")\n \n \n \n \n \n Kanabo appoints Dr Daniel Poulter MP as Non-Executive Director \n \n \n \n \n \n Kanabo Group Plc (LSE:KNB) is pleased to announce that it has appointed Dr Dan Poulter MP as a Non-Executive Director to the board. As both a former UK Government health minister, and as the chairperson of the All-Party Parliamentary Group for Global Health, Dr Poulter has a detailed knowledge of the drugs and medicines regulatory framework in the UK. His blend of medical, governmental, and healthcare policy experience makes him well positioned to support Kanabo's mission to establish and lead a regulated medicinal cannabis market in the UK and Europe.\n \n \n \n \n \n Dr Poulter is a practicing NHS Psychiatrist who believes that prescribed cannabis products could bring considerable health benefits to help people experiencing mental ill health and distress. He has previously been involved in advocating medical cannabis for the benefit of patients through his work on a number of medical and policy bodies.\n \n \n \n \n \n There is no further information required to be disclosed pursuant to Listing Rule 9.6.13 (1) - (6) of the Financial Conduct Authority in respect of \n Dr Poulter\n .\n \n \n \n \n \n \n As part of his appointment, the Company has granted Dr Poulter options over 1,800,000 Ordinary Shares at an exercise price per option of 19.7p.\n \n \n \n \n \n \n \n \n Avihu Tamir, CEO, Kanabo Group, said,\n \n \n \"We are delighted to welcome Dr Dan Poulter, MP as a Non-Executive Director to our board. Dan brings a wealth of knowledge and insight into the business that strengthens our team as we build a medicinal cannabis market in the UK and Europe.\" \n \n \n \n \n \n Dr Daniel Poulter MP, said, \n \n \n \"As a doctor, I am increasingly aware of the potential of cannabis-based medicines. Cannabis products are fast becoming available that could deliver significant improvements to the lives of thousands of patients suffering from conditions ranging from chronic pain to post traumatic stress disorder.\n \n \n \n \n \n Kanabo is an established leader in medical cannabis research and innovation. As such the c...